{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-010591","form_type":"8-K","ticker":"FEMY","cik":"0001339005","company_name":"FEMASYS INC","filed_at":"2026-03-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.881593+00:00","generated_at":"2026-05-15T09:28:05.229786+00:00","sec_items":["1.01","3.02","5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Femasys amends convertible notes, removes anti-dilution, issues 16.4M warrants at $0.58; board adds director","bullets":["Omnibus Amendment removes Share Combination Event Adjustment from $10.5M+ senior secured convertible notes and warrants, effective Dec 31, 2025.","As consideration, lenders receive 16,378,563 Series D-1 Warrants exercisable at $0.58 per share (Nasdaq minimum price on March 19, 2026).","Director Joshua Silverman resigned March 17, 2026; no disagreement. Board appointed Kenneth D. Eichenbaum, M.D., effective March 18, 2026.","Amendment expands Securities Purchase Agreement participation right exclusion to cover Series D-1 Warrants and underlying shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-010591","json":"https://secwatch.observer/filing/0001140361-26-010591.json","markdown":"https://secwatch.observer/filing/0001140361-26-010591.md","text":"https://secwatch.observer/filing/0001140361-26-010591.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1339005/000114036126010591/0001140361-26-010591-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1339005/000114036126010591/ef20068469_form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:28:05.229786+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d4f96525f6cd81aaa17aabffb876eed23d01083a","claim":"FEMASYS INC amended Omnibus Amendment and Consent Agreement with Consenting Holders (effective 2026-03-19).","evidence_excerpt":"On March 19, 2026, the Company entered into an Omnibus Amendment and Consent Agreement (the “Amendment Agreement”) with the holders listed on Schedule I thereto (each, a “Consenting Holder” and collectively, the “Consenting Holders”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1339005/000114036126010591/0001140361-26-010591-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Counterparty","value":"Consenting Holders"},{"label":"Effective","value":"2026-03-19"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}